197 related articles for article (PubMed ID: 31996203)
1. A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease.
De Sousa SMC; Manavis J; Feng J; Wang P; Schreiber AW; Scott HS; Torpy DJ
BMC Endocr Disord; 2020 Jan; 20(1):18. PubMed ID: 31996203
[TBL] [Abstract][Full Text] [Related]
2. Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors.
Re A; Ferraù F; Cafiero C; Spagnolo F; Barresi V; Romeo DP; Ragonese M; Grassi C; Pontecorvi A; Farsetti A; Cannavò S
Front Endocrinol (Lausanne); 2020; 11():591039. PubMed ID: 33281746
[TBL] [Abstract][Full Text] [Related]
3.
De Sousa SMC; Shen A; Yates CJ; Clifton-Bligh R; Santoreneos S; King J; Toubia J; Trivellin G; Lania AG; Stratakis CA; Torpy DJ; Scott HS
Front Endocrinol (Lausanne); 2023; 14():1305606. PubMed ID: 38075079
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
5. Cyclical Cushing's syndrome--a trap for the unwary.
Loh KC
Singapore Med J; 1999 Apr; 40(4):321-4. PubMed ID: 10487094
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological correlates of adrenal Cushing's syndrome.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Mar; 68(3):175-86. PubMed ID: 25425660
[TBL] [Abstract][Full Text] [Related]
7. Double pituitary lesions in three patients with Cushing's disease.
Meij BP; Lopes MB; Vance ML; Thorner MO; Laws ER
Pituitary; 2000 Nov; 3(3):159-68. PubMed ID: 11383480
[TBL] [Abstract][Full Text] [Related]
8. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
[TBL] [Abstract][Full Text] [Related]
9. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
10. PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
[TBL] [Abstract][Full Text] [Related]
11. [Transgenic mice as animal model of Cushing's syndrome].
Helseth A; Bautch VL; Haug E; Holm R; Nesland JM; Fodstad O
Tidsskr Nor Laegeforen; 1993 Jan; 113(2):206-10. PubMed ID: 8381565
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease in two sisters.
Gardner DF; Barlascini CO; Downs RW; Sahni KS
Am J Med Sci; 1989 Jun; 297(6):387-9. PubMed ID: 2544092
[TBL] [Abstract][Full Text] [Related]
13. A case of autonomous cortisol secretion in a patient with subclinical Cushing's syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone.
Sakaguchi C; Ashida K; Kohashi K; Ohe K; Fujii Y; Yano S; Matsuda Y; Sakamoto S; Sakamoto R; Oda Y; Nomura M; Ogawa Y
BMC Endocr Disord; 2019 Jan; 19(1):13. PubMed ID: 30670014
[TBL] [Abstract][Full Text] [Related]
14. Fluctuating hyper-hypocortisolaemia: a variant of Cushing's syndrome.
Liebowitz G; White A; Hadani M; Gross DJ
Clin Endocrinol (Oxf); 1997 Jun; 46(6):759-63. PubMed ID: 9274708
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Cushing's syndrome.
Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
[TBL] [Abstract][Full Text] [Related]
17. Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.
Tan EU; Ho MS; Rajasoorya CR
Pituitary; 2000 Oct; 3(2):117-22. PubMed ID: 11141695
[TBL] [Abstract][Full Text] [Related]
18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
19. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.
Lecoq AL; Viengchareun S; Hage M; Bouligand J; Young J; Boutron A; Zizzari P; Lombès M; Chanson P; Kamenický P
Endocr Relat Cancer; 2016 May; 23(5):433-43. PubMed ID: 27080473
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological study of Cushing's disease with large pituitary adenoma.
Ikeda H; Yoshimoto T; Ogawa Y; Mizoi K; Murakami O
Clin Endocrinol (Oxf); 1997 Jun; 46(6):669-79. PubMed ID: 9274697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
